Contribute Try STAT+ Today

As the Biden White House attempts to fashion its health policies, a coalition of consumer and patient advocacy groups is urging the administration not to tap Janet Woodcock, a long-standing Food and Drug Administration official, to head the embattled agency.

Woodcock is currently serving as acting FDA commissioner, but has at various times led the division that regulates medicines. For that reason, the groups maintained she played a key role in fomenting the opioid crisis, citing government reports that blamed the FDA in part for certain policies and a lack of oversight that contributed to the epidemic across the U.S.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • personally, the disqualifier for Woodcock is the DMD drug approval debacle. The opioid issue is much more nuanced than most would like to believe – whatever blame the FDA bears is more gray than black and white.
    Agree a qualified outsider is preferred over a long time insider.

Comments are closed.